A targeting peptide improves adenovirus-mediated transduction of a glioblastoma cell line

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2093-2098

  Wang, Dongyang ^a   Li, Wenbo ^a   Zhang, Hang ^a   Mao, Qinwen ^b   Xia, Haibin ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adenovirus; Human glio blastoma; Phage display; Targeting

Indexed keywords

ADENOVIRUS VECTOR; POLYPEPTIDE; SERYLTRYPTOPHYLASPARTYLISOLEUCYLALANYLTRYPTOPHYLPROPYLPROPYLLEUCYLLYSYLVALYLPROLINE; UNCLASSIFIED DRUG; ADENOVIRUS RECEPTOR; PEPTIDE LIBRARY; VIRUS RECEPTOR;

ARTICLE; BACTERIOPHAGE; BINDING AFFINITY; BIOPANNING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE INSERTION SEQUENCE; GLIOBLASTOMA; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; VIRAL GENE DELIVERY SYSTEM; ADENOVIRIDAE; BIOSYNTHESIS; BRAIN NEOPLASMS; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; PEPTIDE LIBRARY; PROCEDURES; TUMOR CELL LINE; VIRUS ATTACHMENT;

ADENOVIRIDAE; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENETIC THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HEK293 CELLS; HUMANS; PEPTIDE LIBRARY; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC; VIRUS ATTACHMENT;

EID: 84898605848     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3065     Document Type: Article

References (32)

1. Breyer B, Jiang W, Cheng H, et al: Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 1: 149-162, 2001
2. Kim M, Zinn KRB, Barnett G, et al: The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer 38: 1917-1926, 2002
3. Wickham TJ, Roelvink PW, Brough, et al: Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol 14: 1570-1573, 1996
4. Krasnykh VN, Mikheeva GV, Douglas JT, et al: Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 70: 6839-6846, 1996
5. Tomko RP, Xu R and Philipson L: HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94: 3352-3356, 1997
6. Bergelson JM, Cunningham JA, Droguett G, et al: Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 andd 5. Science 275: 1320-1323, 1997
7. Bergelson JM, Krithivas A, Celi L, et al: The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 72: 415-419, 1998
8. Roelvink PW, Lizonova A, Lee JG, et al: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E and F. J Virol 72: 7909-7915, 1998
9. Wickham TJ, Matthias P, Cheresh DA, et al: Integrins ?v?3 and ?v?5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319, 1993
10. Nemerow GR, Pache L, Reddy V and Stewart PL: Insights into adenovirus host cell interactions from structural studies. Virology 384: 380-388, 2009
11. Eto Y, Gao JQ, Sekiguchi F, et al: PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J Gene Med 7: 604-612, 2005
12. Wortmann A, Vöhringer S, Engler T, et al: Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies. Mol Ther 16: 154-162, 2008
13. Sakurai F, Mizuguchi H and Hayakawa T: Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector. Gene Ther 10: 1041-1048, 2003
14. Wohlfahrt ME, Beard BC, Lieber A and Kiem HP: A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res 67: 8783-8790, 2007
15. Havenga MJ, Lemckert AA, Grimbergen JM, et al: Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 75: 3335-3342, 2001
16. Goossens PH, Havenga MJ, Pieterman E, et al: Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber. Arthritis Rheum 44: 570-577, 2001
17. Xia H, Anderson B, Mao Q and Davidson BL: Recombinant human adenovirus: Targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol 74: 11359-11366, 2000
18. Rittner K, Schreiber V, Erbs P and Lusky M: Targeting of adenovirus vectors carrying a tumor cell-specific peptide: In vitro and in vivo studies. Cancer Gene Ther 14: 509-518, 2007
19. Jullienne B, Vigant F, Muth E, et al: Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid. Gene Ther 16: 1405-1415, 2009
20. Liu S, Mao Q, Zhang W, et al: Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells. Biosci Rep 29: 103-109, 2009
21. Di B, Mao Q, Zhao J, et al: A rapid generation of adenovirus vector with a genetic modification in hexon protein. J Biotechnol 157: 373-378, 2012
22. Giordano RJ, Cardó-Vila M, Lahdenranta J, et al: Biopanning and rapid analysis of selective interactive ligands. Nat Med 7: 1249-1253, 2001
23. Alexander BL, Ali RR, Alton EW, et al: Progress and prospects: Gene therapy clinical trials (part 1). Gene Ther 14: 1439-1447, 2007
24. Aiuti A, Bachoud-Lévi AC, Blesch A, et al: Progress and prospects: Gene therapy clinical trials (part 2). Gene Ther 14: 1555-1563, 2007
25. Volpers C, Thirion C, Biermann V, et al: Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid. J Virol 77: 2093-2104, 2003
26. Haisma HJ, Grill J, Curiel DT, et al: Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther 7: 901-904, 2000
27. Arap W, Pasqualini R and Ruoslahti E: Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279: 377-380, 1998
28. Curnis F, Arrigoni G, Sacchi A, et al: Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res 62: 867-874, 2002
29. Pasqualini R, Koivunen E, Kain R, et al: Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 60: 722-727, 2000
30. Rasmussen UB, Schreiber V, Schultz H, et al: Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther 9: 606-612, 2002
31. Belousova N, Krendelchtchikova V, Curiel DT and Krasnykh V: Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol 76: 8621-8631, 2002
32. Vigne E, Mahfouz I, Dedieu JF, et al: RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection. J Virol 73: 5156-5161, 1999